On March 24, 2021, the Board of Directors (the “Board”) of Eloxx Pharmaceuticals, Inc. (the “Company”) accepted the resignation of Mr. Stephen MacDonald as Vice President, Finance and Accounting, and Treasurer, effective March 26, 2021. Gary D. Rakers, 37, who joined with the Company in January 2020 and previously served as Corporate Controller and Assistant Treasurer, was promoted to Executive Director, Finance and Accounting and Corporate Controller. The Board appointed Mr. Rakers as principal financial and accounting officer and Treasurer effective March 26, 2021.